- Home
- ZKH vs DCTH Comparison
ZKH vs DCTH Comparison
Compare ZKH & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKH
- DCTH
- Stock Information
- Founded
- ZKH 1998
- DCTH 1988
- Country
- ZKH China
- DCTH United States
- Employees
- ZKH N/A
- DCTH N/A
- Industry
- ZKH
- DCTH Medical/Dental Instruments
- Sector
- ZKH
- DCTH Health Care
- Exchange
- ZKH Nasdaq
- DCTH Nasdaq
- Market Cap
- ZKH 523.9M
- DCTH 518.0M
- IPO Year
- ZKH 2023
- DCTH N/A
- Fundamental
- Price
- ZKH $2.92
- DCTH $11.63
- Analyst Decision
- ZKH Buy
- DCTH Strong Buy
- Analyst Count
- ZKH 1
- DCTH 4
- Target Price
- ZKH $4.00
- DCTH $22.75
- AVG Volume (30 Days)
- ZKH 57.8K
- DCTH 476.1K
- Earning Date
- ZKH 05-20-2025
- DCTH 05-13-2025
- Dividend Yield
- ZKH N/A
- DCTH N/A
- EPS Growth
- ZKH N/A
- DCTH N/A
- EPS
- ZKH N/A
- DCTH N/A
- Revenue
- ZKH $1,200,328,532.00
- DCTH $37,205,000.00
- Revenue This Year
- ZKH $11.95
- DCTH $128.78
- Revenue Next Year
- ZKH $11.23
- DCTH $54.07
- P/E Ratio
- ZKH N/A
- DCTH N/A
- Revenue Growth
- ZKH 0.46
- DCTH 1701.69
- 52 Week Low
- ZKH $2.62
- DCTH $4.26
- 52 Week High
- ZKH $14.48
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- ZKH 31.82
- DCTH 44.80
- Support Level
- ZKH $2.86
- DCTH $11.20
- Resistance Level
- ZKH $3.08
- DCTH $11.81
- Average True Range (ATR)
- ZKH 0.20
- DCTH 0.98
- MACD
- ZKH -0.04
- DCTH 0.04
- Stochastic Oscillator
- ZKH 8.11
- DCTH 51.25
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.